Latest technology news and innovations
The first trailer for "Avengers: Doomsday" reveals a massive superhero lineup tackling multiverse chaos, set for release on December 18, 2026.
SpaceX has shifted the launch of Starship Flight 13 to July 23, addressing technical issues following an abort at the previous launch attempt.
Federal health officials continue investigations into a cyclospora outbreak linked to Taylor Farms lettuce, despite a false positive test result.
Observations from the James Webb Space Telescope reveal an unexplained infrared signal on Pluto and Titan, hinting at shared chemical processes.
Fifty years since Viking 1's historic Mars landing, NASA is advancing aerial exploration with plans for future helicopter missions on the Red Planet.
Bristol Myers Squibb is partnering with NVIDIA to enhance drug discovery through a new supercomputer, aiming for deeper insights in oncology and neurodegeneration.
Proposed Medicare fee schedule changes may incentivize doctors to provide more support for smoking cessation, increasing reimbursements for counseling services.
GSK has ceased its efforts to develop a chronic cough therapy, citing the challenges faced during clinical trials.
Drug shortages in the U.S. have surged to 227, while GSK halts development of its chronic cough treatment after disappointing trial results.
The recent U.S. policy on testosterone screenings highlights disparities in access to hormone therapy, notably affecting LGBTQ+ individuals.
Sonothera's ultrasound technology promises treatments for Duchenne muscular dystrophy, but experts remain skeptical amid a lack of clinical data.
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.
MDCalc is enhancing trust in clinical decision-making by implementing a new quality-rating system for its calculators, impacting how physicians use these tools.
MAHA's recent initiatives signal a pivotal shift in the dialogue around mental health care, emphasizing deprescribing while sidelining concrete solutions.
Sales under the U.S. drug discount program reached $100 billion in 2025, driven largely by high-cost medications.
HCA Healthcare projects a significant profit drop due to a surge in uninsured patients after subsidy changes under the Affordable Care Act.
Anthropic's Claude Science software targets biopharma research, showcasing AI's positive potential amidst ongoing public skepticism.
The ex-Akero Therapeutics team has formed Avere Therapeutics, targeting immunology with an oral IL-23 inhibitor from a Chinese source.
Health workers in the DRC protest unpaid wages as Ebola cases rise, highlighting the urgent need for coordinated global health responses.
This week's biotech podcast discusses rising health insurance costs and the whistleblower case against an insurer, alongside industry developments.